Your Thyroid Might Hold a Key to Fighting Aggressive Prostate Cancer

A hormone produced by your thyroid gland might be secretly fueling prostate cancer growth, but researchers have discovered a way to turn this connection into a potential treatment. An international study led by Umeå University in Sweden and the Medical University of Vienna found that blocking a specific thyroid hormone receptor significantly slowed tumor growth in laboratory and animal studies.

How Does the Thyroid Connection Work?

The culprit is a receptor called thyroid hormone receptor Beta (TRβ), which binds to the thyroid hormone triiodothyronine (T3). When researchers activated T3 in laboratory experiments, prostate cancer cells multiplied rapidly. However, when they blocked the TRβ receptor using a research compound called NH-3, cancer cell growth dropped significantly.

"The results indicate that the receptor in question is a driving force in the growth of cancer. Substances that block it could thus be a target for future drugs against prostate cancer," said Lukas Kenner, visiting professor at Umeå University who led the study.

What Makes This Discovery Particularly Promising?

The thyroid-blocking approach showed special promise against castration-resistant prostate cancer, which is notoriously difficult to treat. This type continues growing even when testosterone levels are reduced through standard treatments. In mouse studies, tumors treated with the thyroid-blocking compound remained smaller or progressed much more slowly than untreated ones.

The blocking mechanism works by eliminating androgen receptor signals, which are normally activated by testosterone and play a central role in prostate cancer development. Patient data supports these findings, showing:

• Elevated TRβ Levels: Prostate tumor tissue contained higher levels of the thyroid hormone receptor compared to healthy tissue
• Genetic Mutations: Many prostate cancer patients had mutations that altered thyroid hormone signaling pathways
• Treatment Resistance: The approach was particularly effective in models representing hard-to-treat, aggressive forms of the disease

What Are the Next Steps and Limitations?

While promising, researchers acknowledge this approach requires careful balance. "Of course, it is a balancing act not to change the hormonal balance in the thyroid gland more than necessary to fight cancer in another part of the body, and it will probably not be a solution for all types of prostate cancer," Kenner explained.

Prostate cancer affects millions of men worldwide as the second most common male cancer. When caught early, doctors typically reduce testosterone levels to slow growth. However, many patients eventually become resistant to this treatment, leaving limited options. The thyroid connection could open new treatment pathways, possibly in combination with existing therapies, though more research is needed to determine what clinical treatment might look like.